Explora Nano

Lipid-made nanoparticles are small delivery vehicles that can encapsulate therapeutics like mRNA and drugs. These tiny containers help to protect therapies until they are delivered into cells where they have better effects. A huge portion of the worldwide population have them in their bodies, thanks to mRNA COVID19 vaccines from Pfizer and Moderna. A lot of companies and laboratories are finding new therapies everyday; however, putting these therapies into nanoparticles requires dedicated equipment that cost thousands or hundreds of thousands of dollars and lengthy process to get the best recipe. This project is researching and developing a kit with all the reagents that are required to produce nanoparticles and encapsulate therapeutic molecules. By decreasing the production barriers, this kit will support research labs and biotech to bring therapies closer to clinical testing. The work with the partner organization with help us to validate the commercial potential of our proposed kit.

Faculty Supervisor:

Julia Valdemarin Burnier

Student:

Partner:

Springboard Atlantic Inc.

Discipline:

Life Sciences

Sector:

Health and Related Sciences & Technology; Nanotechnology; Biomanufacturing

University:

Research Institute of the McGill University Health Centre

Program: